1-20 of 27
Isabelle Plantier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia

Clinical Trials & Observations
Yves Chalandon, Philippe Rousselot, Sylvie Chevret, Jean-Michel Cayuela, Rathana Kim, Françoise Huguet, Patrice Chevallier, Carlos Graux, Anne Thiebaut-Bertrand, Sylvain Chantepie, Xavier Thomas, Laure Vincent, Céline Berthon, Yosr Hicheri, Emmanuel Raffoux, Martine Escoffre-Barbe, Isabelle Plantier, Magalie Joris, Pascal Turlure, Florence Pasquier, Amine Belhabri, Gabrielle Roth Guepin, Sabine Blum, Michael Gregor, Marina Lafage-Pochitaloff, Julie Quessada, Véronique Lhéritier, Emmanuelle Clappier, Nicolas Boissel, Hervé Dombret
Journal: Blood
Blood (2024) 143 (23): 2363–2372.
https://doi.org/10.1182/blood.2023023502
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

Laurence Legros, Françoise Boyer perrard, Dana Ranta, Lydia Roy, Mario Ojeda-Uribe, Stephane Giraudier, Nathalie Parquet, Jean Christophe Ianotto, Mathieu Wemeau, Isabelle Plantier, Franck E. Nicolini, Eric Lippert, Pascale Cony-Makhoul, Fiorenza Barraco, Laure Stalnikiewicz, Frederic Garban, Brigitte Dupriez, Francois Girodon, Anne Brignier, Yazid Arkam, Mathieu Meunier, Chloe James, Valérie Rolland-Neyret, Valerie Ugo, Pierre Morel, Marie C Bene, Jean-Jacques Kiladjian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6847–6849.
https://doi.org/10.1182/blood-2022-156632
Published: 2022
Journal Articles

The Omission of High-Dose Cytarabine during Consolidation Therapy of Ph-Positive ALL Patients Treated with Nilotinib and Low-Intensity Chemotherapy Results in an Increased Risk of Relapses Despite Non-Inferior Levels of Late BCR-ABL1 MRD Response. First Results of the Randomized Graaph-2014 Study

Philippe Rousselot, Yves Chalandon, Sylvie Chevret, Jean-Michel Cayuela, Francoise Huguet, Patrice Chevallier, Carlos Graux, Anne Thiebaut-Bertrand, Sylvain Chantepie, Xavier Thomas, Laure Vincent, Celine Berthon, Norbert Vey, Emmanuel Raffoux, Martine Escoffre-Barbe, Isabelle Plantier, Jean Pierre Marolleau, Pascal Turlure, Florence Pasquier, Amine Belhabri, Gabrielle Roth Guepin, Olivier Spertini, Veronique Lheritier, Emmanuelle Clappier, Nicolas Boissel, Hervé Dombret
Journal: Blood
Blood (2021) 138 (Supplement 1): 512.
https://doi.org/10.1182/blood-2021-148843
Published: 2021
Journal Articles

Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial

Rathana KIM, Philippe Rousselot, Jean-Michel Cayuela, Yves Chalandon, Marie Passet, Xavier Thomas, Nicole Straetmans, Patrice Chevallier, Francoise Huguet, Celine Berthon, Georg Stüssi, Sébastien Maury, Sylvain Chantepie, Jean-Baptiste Micol, Isabelle Plantier, Sylvie Chevret, Jean Soulier, Norbert Ifrah, Veronique Lheritier, Hervé Dombret, Nicolas Boissel, Emmanuelle Clappier
Journal: Blood
Blood (2021) 138 (Supplement 1): 3478.
https://doi.org/10.1182/blood-2021-150126
Published: 2021
Journal Articles

Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively

Maël Heiblig, MD, Hélène Labussière, MD, Marie Virginie Larcher, MD, Gaelle Fossard, MD, Marie Balsat, MD, Sophie Ducastelle, MD, Sandrine Loron, MD, Sandrine Hayette, PhD, Sarah Huet, Pierre Sujobert, MD PhD, Fiorenza Barraco, MD, Xavier Thomas, MD PhD, Alice Marceau, Delphine Lebon, MD, Laure Goursaud, Isabelle Plantier, MD, Laure Stalnikiewich, Cecile Frimat, Nathalie Cambier, Nicolas Duployez, PharmD, PhD, Herve Ghesquieres, MD PhD, Claude Preudhomme, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-141890
Published: 2020
Journal Articles

Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial

Jean-Michel Cayuela, Francois Lay, MD, Yves Chalandon, Philippe Rousselot, MD PhD, Xavier Thomas, MD PhD, Violaine Havelange, MD, Francoise Huguet, MD, Patrice Chevallier, MD, Anne Thiebaut-Bertrand, Sylvain Chantepie, MD, Nicolas Boissel, MD PhD, Norbert Vey, MD PhD, Martine Escoffre-Barbe, MD, Franciane Paul, Celine Berthon, MD PhD, Isabelle Plantier, MD, Mathilde Hunault, MD PhD, Carlos Graux, Veronique Lheritier, Sylvie Chevret, MD PhD, Hervé Dombret
Journal: Blood
Blood (2019) 134 (Supplement_1): 1295.
https://doi.org/10.1182/blood-2019-124029
Published: 2019
Journal Articles

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

Berengere Gruson, MD, Magalie Joris, Olivier Nibourel, Véronique Harrivel, MD, Nathalie Cambier, MD, Pauline Lionne, Bachra Choufi, Celine Rodriguez, Cecile Frimat, Isabelle Plantier, MD, Laure Stalnikiewicz, Maxime Bemba, Céline Berthon, MD PhD, Claude Preudhomme, Pierre Morel, MD, Jean-Pierre Marolleau, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2679.
https://doi.org/10.1182/blood-2018-99-116144
Published: 2018
Journal Articles

Outcome of Patients Receiving Venetoclax for Chronic Lymphocytic Leukemia (CLL) in Real-Life Clinical Practice: Results of the French ATU Program on Behalf of the Filo Group

Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, MD, Sandy Amorim, MD, Florence Cymbalista, MD PhD, Charles Herbaux, MD, Sophie de Guibert, MD, Damien Roos-Weil, MD, Benedicte Hivert, MD, Thérèse Aurran, MD, Jehan Dupuis, MD, Anaise Blouet, MD, Emmanuelle Tchernonog, MD, Kamel Laribi, MD, Natalia Dmytruk, MD, Pierre Morel, Anne-Sophie Michallet, MD PhD, Caroline Dartigeas, MD, Laure Farnault, MD, Anne Lavaud, MD, Isabelle Plantier, MD, Jacques-Olivier Bay, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Pierre Feugier, Loic Ysebaert, MD PhD, Romain Guieze, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2018-99-118622
Published: 2018
Journal Articles

Myelofibrosis in Real Life: Findings from the French Intergroup of Myeloproliferative Neoplasms (FIM) Registry

Brigitte Dupriez, MD, Sylvie Chevret, MD PhD, Jean-Christophe Ianotto, MD, Francoise Boyer, MD, Pascale Cony-Makhoul, MD, Gabriel Etienne, MD PhD, Mathieu Wemeau, MD, Jérome Rey, Laurent Knoops, MD PhD, Jean-Loup Demory, MD, Eric Lippert, PhD, Francois Girodon, MD PhD, Laurence Legros, MDPhD, Anne Vekhoff, MD, Stephane Courby, MD, Fabienne Vacheret, MD, Nathalie Cambier, MD, Stephane Giraudier, MD PhD, Suzanne Tavitian, MD, Kamel Laribi, Sandra Malak, Dana Ranta, MD, Fiorenza Barraco, MD, Isabelle Plantier, MD, Sophie Dupire, Marc Simon, MD, Selim Corm, MD, Ahmad AL Jijakli, MD, Philippe Rodon, MD, Lise Willems, MD PhD, Bohrane Slama, MD, Ronan Le Calloch, MD, Pierre Morel, MD, Valerie Ugo, MD PhD, Jean-Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3128.
https://doi.org/10.1182/blood.V128.22.3128.3128
Published: 2016
Journal Articles

Epidemiology of Adults AML in Nord-Pas De Calais and Picardy

Christophe Roumier, MD, Céline Rodriguez, Cécile Frimat, Céline Berthon, MD PhD, Carole Delattre, MD, Marc Wetterwald, MD PhD, Jose Fernandes, MD, Agnes Daudignon, Isabelle Plantier, MD, Agnes Charpentier, MD, Stéphane Darre, MD, Bachra Choufi, MD, Laure Stalnikiewicz, MD, Christine Ghevaert, MD, Jean-Pierre Marolleau, MD PhD, Veronique Harrivel, MD, Olivier Nibourel, PhD, Catherine Roche, PhD, Bruno Quesnel, MD PhD, Claude Preudhomme, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 2281.
https://doi.org/10.1182/blood.V124.21.2281.2281
Published: 2014
Journal Articles

Molecular Prognostic Factors in Acute Myeloid Leukemia (AML) Patients Receiving First Line Therapy with Azacytidine (AZA)

Judith Desoutter, Julie Gay, MD, Céline Berthon, MD PhD, Lionel Ades, MD, Jean Pierre Marolleau, MD PhD, Sandrine Geffroy, Isabelle Plantier, MD, Marceau Alice, MD, Nathalie Helevaut, Jose Fernandes, MD, Maxime Bemba, MD, Cécile Frimat, Julien Labreuche, Olivier Nibourel, Christophe Roumier, Martin Figeac, Pierre Fenaux, MD PhD, Bruno Quesnel, MD PhD, Aline Renneville, Claude Preudhomme, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 482.
https://doi.org/10.1182/blood.V124.21.482.482
Published: 2014
Journal Articles

AML At First Relapse: A Real Life Picture

Eileen Mary Boyle, MD, Claude Preudhomme, MD, PhD, Olivier Nibourel, Catherine Roche-Lestienne, PhD, Gareth J Morgan, MD PhD, Brigitte Dupriez, MD, Isabelle Plantier, MD, Berengere Gruson, MD, Jean Pierre Marolleau, MD, PhD, Delphine Lebon, MD, Jose Fernandes, MD, Christophe Willekens, Bruno Quesnel, MD, PhD, Céline Berthon, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3895.
https://doi.org/10.1182/blood.V122.21.3895.3895
Published: 2013
Journal Articles

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Mathilde Hunault-Berger, MD, PhD, Thibaut Leguay, MD, Françoise Huguet, Stéphane Leprêtre, MD, Eric Deconinck, MD, PhD, Mario Ojeda Uribe, MD, Caroline Bonmati, MD, Pierre Bories, MD, Chantal Himberlin, MD, Patrice Chevallier, MD, Philippe Rousselot, MD, PhD, Oumedaly Reman, MD, Marie-Laure Boulland, MD, Severine Lissandre, MD, Pascal Turlure, MD, Didier Bouscary, Laurence Sanhes, MD, Ollivier Legrand, MD, PhD, Isabelle Plantier, MD, Frédérique Orsini Piocelle, MD, Véronique Lhéritier, Elodie Boucher, Yann Godfrin, PhD, Norbert Ifrah, Hervé Dombret, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1473.
https://doi.org/10.1182/blood.V120.21.1473.1473
Published: 2012
Journal Articles

90-Yttrium Ibritumomab Tiuxetan (Zevalin) and BEAM Chemotherapy (Z-BEAM) Vs BEAM for Autologous Stem Cell Transplantation in Lymphoma: Toxicity and Long Term Outcome From a Retrospective Multicentric Study of 123 Patients.

Louis Terriou, MD, Hanane Gasmi, Salomon Manier, MD, Isabelle Plantier, MD, Marc Wetterwald, MD, PhD, Pauline lionne-Huyghe, MD, Daniela Robu, MD, Sabine Tricot, MD, Ibrahim Yakoub-Agha, MD, PhD, Nicolas Simon, PhD, Pascal Odou, PhD, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2726.
https://doi.org/10.1182/blood.V120.21.2726.2726
Published: 2012
Journal Articles

Gemtuzumab Ozogamicin-Based Salvage, Followed by Allogeneic Hematopoietic Stem Cell Transplantation, Is Highly Effective in Young Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Relapse

Marie-Anne Hospital, Christian Recher, MD, PhD, Xavier Thomas, Emmanuelle Tavernier, Bruno Lioure, Cécile Pautas, Aurore Perrot, Thorsten Braun, MD, Thomas Cluzeau, Jean-Valère Malfuson, Jerome Tamburini, Céline Berthon, MD, Alexis Magda, Chantal Himberlin, Stephane de Botton, Edouard Randriamalala, Isabelle Plantier, Madalina Uzunov, Philippe Rousselot, Norbert Ifrah, Herve Dombret, Nicolas Boissel
Journal: Blood
Blood (2011) 118 (21): 2603.
https://doi.org/10.1182/blood.V118.21.2603.2603
Published: 2011
Journal Articles

L-Asparaginase-Loaded Red Blood Cells Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph- ALL): First Results of the GRASPALL/GRAALL-SA2-2008 Study

Mathilde Hunault, MD, PhD, Thibault Legay, MD, Françoise Huguet, MD, Stéphane Leprêtre, MD, Eric Deconinck, MD, PhD, Mario Ojeda Uribe, MD, Caroline Bonmati, MD, Bruno Lioure, Catherine Himberlin, MD, Patrice Chevallier, MD, Philippe Rousselot, MD, PhD, Oumedaly Reman, MD, Marie-Laure Boulland, MD, Véronique Lhéritier, Severine Lissandre, MD, Pascal Turlure, MD, Didier Bouscary, MD, PhD, Laurence Sanhes, MD, Ollivier Legrand, Isabelle Plantier, Frédérique Orsini Piocelle, MD, David Liens, MD, Yann Godfrin, PhD, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 2579.
https://doi.org/10.1182/blood.V118.21.2579.2579
Published: 2011
Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, MD, PhD, Dominique Bordessoule, Jean-Noel Bastie, MD, PhD, Ollivier Legrand, Xavier Thomas, MD, PhD, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, MD, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, MD, PhD, Estelle Henry, Philippe Rousselot, MD, PhD, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 6.
https://doi.org/10.1182/blood.V118.21.6.6
Published: 2011
Journal Articles

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Clinical Trials & Observations
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Norbert Vey, Christian Recher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Célia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Francoise Isnard, Anne Marfaing-Koka, Stephane de Botton, Youcef Chelghoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, C. L. Beach, Lionel Adès, Pierre Fenaux, on behalf of the Groupe Francophone des Myelodysplasies (GFM)
Journal: Blood
Blood (2011) 117 (2): 403–411.
https://doi.org/10.1182/blood-2010-06-289280
Published: 2011
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Clinical Trials & Observations
Bertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, Gérard Lepeu, Isabelle Plantier, Sylvie Castaigne, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban, Karim Belhadj, Dominique Bordessoule, Christophe Fermé, Hervé Tilly
Journal: Blood
Blood (2010) 116 (12): 2040–2045.
https://doi.org/10.1182/blood-2010-03-276246
Published: 2010
Includes: Supplemental data